GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tivic Health Systems Inc (NAS:TIVC) » Definitions » Market Cap

Tivic Health Systems (Tivic Health Systems) Market Cap : $0.69 Mil (As of May. 18, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tivic Health Systems Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tivic Health Systems's share price for the quarter that ended in Dec. 2023 was $1.8. Tivic Health Systems's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1.47 Mil. Therefore, Tivic Health Systems's market cap for the quarter that ended in Dec. 2023 was $2.64 Mil.

Tivic Health Systems's quarterly market cap declined from Jun. 2023 ($3.14 Mil) to Sep. 2023 ($2.54 Mil) but then increased from Sep. 2023 ($2.54 Mil) to Dec. 2023 ($2.64 Mil).

Tivic Health Systems's annual market cap declined from Dec. 2021 ($37.69 Mil) to Dec. 2022 ($6.19 Mil) and declined from Dec. 2022 ($6.19 Mil) to Dec. 2023 ($2.64 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tivic Health Systems's Enterprise Value for Today is $-2.31 Mil.


Tivic Health Systems Market Cap Historical Data

The historical data trend for Tivic Health Systems's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tivic Health Systems Market Cap Chart

Tivic Health Systems Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
- - 37.69 6.19 2.64

Tivic Health Systems Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.19 4.47 3.14 2.54 2.64

Competitive Comparison of Tivic Health Systems's Market Cap

For the Medical Devices subindustry, Tivic Health Systems's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tivic Health Systems's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's Market Cap distribution charts can be found below:

* The bar in red indicates where Tivic Health Systems's Market Cap falls into.



Tivic Health Systems Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Tivic Health Systems's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$1.8*1.46609
=$2.64

Tivic Health Systems's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$1.8*1.46609
=$2.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tivic Health Systems  (NAS:TIVC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Tivic Health Systems Market Cap Related Terms

Thank you for viewing the detailed overview of Tivic Health Systems's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Tivic Health Systems (Tivic Health Systems) Business Description

Traded in Other Exchanges
N/A
Address
25821 Industrial Boulevard, Suite 100, Hayward, CA, USA, 94545
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Executives
Sheryle Bolton director 55 ALMADEN BLVD, SAN JOSE CA 95113
Dean Zikria director C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538
Jennifer Ernst director, officer: Chief Executive Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Blake Gurfein officer: Chief Scientific Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Ryan Sabia officer: Chief Operating Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Kimberly Ann Bambach officer: Interim CFO 25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545
Karen Drexler director C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Veronica Cai officer: Chief Financial Officer C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080
John Claude 10 percent owner 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Briana Benz officer: Chief Financial Officer 750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025